Some Doctors Won’t Take Industry Payments

Search

Topics

Uncategorized

Links
- FDA

Case Review Form

* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of injured person
(mm-dd-yyyy):

Name of medical device:

Please describe any problems or injuries caused by the device:

Other Info:

No Yes, I agree to the Parker & Waichman, LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker & Waichman, LLP monthly newsletter, InjuryAlert.

Archives

Latest Medical Device News

20 mEq Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP - Recall of one lot due to possible incorrect bar code for 5% Dextrose Injection, USP. The incorrect bar code could lead to a medication error resulting in the wrong drug being delivered to a patient if a bar code system is used to confirm the medication.
Gravity Compensating Accessory, High Pressure Range, Sterile, Single Use, by Integra NeuroSciences - Recall issued because the devices may leak cerebrospinal fluid which may cause inflammation of brain, spinal cord, or abdominal membranes, pressure on the wound created by implantation of the device, or failure of the shunt system.
Greenline-D MacIntosh No. 3 Laryngoscope Blades - Class 1 recall due to potential for piece of blade to break off during procedure.
Healon D Ophthalmic Viscosurgical Device - Recall of one lot of the product because some of the tested OVD syringes had endotoxin levels above the required limit.
Hydromorphone HCl 2 mg Tablets - Nationwide recall of a single lot due to potential for oversized tablets.
Innohep (tinzaparin sodium injection) - [UPDATE] Dear Healthcare Professional letter issued re: increased risk of death in elderly patients with renal insufficiency
October 2008 Safety Labeling Changes - Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of drug Prescribing Information, plus Patient Package Inserts and Medication Guides.
Oral Sodium Phosphate (OSP) Products for Bowel Cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription) - Reports of acute phosphate nephropathy, a type of acute kidney injury, associated with the use of oral sodium phosphate products.
Stryker Custom Cranial Implant Kits - Class 1 recall because sterility cannot be assured.
Terumo Cardiovascular Systems Tenderflow Pediatric Arterial Cannulae - Worldwide recall involving 21 lot codes, due to reports of difficulty retracting the introducer from the cannula.
Weight Loss Pills - Products contain undeclared, active pharmaceutical ingredients that may put consumers' health at risk.

Some Doctors Won’t Take Industry Payments

April 17th, 2008 joshua

The New York Times found several doctors who’ve stopped accepting payments to appear at conferences and speak on behalf of a drug or medical device, or sit on advisory boards of these industries.

This is uncommon these days as we’re learning more and more every day of doctors who’ve been spoon-fed cash in exchange for endorsement of their products. These endorsements go far beyond posing with a bottle of the pills for a billboard, however. Physicians are accepting handsome payments from drug companies for studies and professional opinions which the drug company can use to gain market clearances and drive up sales.

The U.S. Senate is currently drafting legislation which aims to force the pharmaceutical and bio-tech industries to be more transparent on how it spends a lot of its money. More and more we’re reading about drugs which gained FDA approval on the heels of evidence which the drug company bought.

The physicians interviewed by The Times say it’s important for physicians to continue working on such research, but to restore some sort of ethics to the practice of medicine. One said the atmosphere has changed concerning the money, and when he first started accepting these payments in the 1980s, he thought it was a natural response to the value of his opinion.

But after he finished a public project, he was chastised on the Web for taking money from pharmaceutical companies, and though he claims to have never altered his opinion because of money, he decided to stop accepting the payments.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.